The global migraine drugs market is estimated to grow at a CAGR of over 9% during the forecast period. The market growth is attributed to the rising incidences of migraines, extreme exposure to screens and stressed lifestyle, presence of robust pipeline, and increasing R&D expenditures. Further, the development of novel drugs and the approvals by the US FDA is expected to provide growth opportunities to the market in the near future. Migraine is a neurological disease with extremely incapacitating neurological symptoms. As per the Migraine Research Foundation in 2019, migraine is the 6th most disabling illness across the globe.

Request a free sample of our report on Global Migraine Drugs Market: https://www.omrglobal.com/request-sample/migraine-drugs-market

Migraine attacks are caused due to various disabling symptoms including visual disturbances, dizziness, nausea, and others. Every 10 seconds, someone in the US goes to the emergency room complaining of headaches, and around 1.2 million visits are for acute migraine attacks. Most sufferers experience migraine attacks once or twice a month, more than 4 million people have a chronic daily migraine, with at least 15 migraine days per month. The migraine patients use 2.5 times the amount of prescription drugs and have six times as many diagnostic tests and services. Thus, the increasing prevalence of migraine increases the demand for more and more therapeutics for getting relief, which in turn, drives the overall market.

A full report of Global Migraine Drugs Market Is available at :

https://www.omrglobal.com/industry-reports/migraine-drugs-market



Global Migraine Drugs Market Segmentation

By Treatment Type

Acute Migraine Treatment

Preventive Migraine Treatment

By Route of Administration

Oral

Injectable

Others (Spray)

Regional Analysis

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe

Asia-Pacific

China

India

Japan

Rest of Asia-Pacific

Rest of the World

Company Profiles

Allergan Plc

Amgen Inc.

Astrazeneca PLC

Bausch Health Companies Inc.

Biohaven Pharmaceutical Holding Co. Ltd.

Dr. Reddy's Laboratories Ltd.

Eli Lilly & Co.

GlaxoSmithKline Plc

H. Lundbeck A/S

Johnson & Johnson Services Inc.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/migraine-drugs-market

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.



For More Information, Visit https://www.omrglobal.com/



Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404